The Egyptian Cabinet’s Media Center has responded to circulating claims regarding reports of counterfeit breast cancer medications in the local market. Whenever counterfeit batches are detected in any country, the company issues a general circular to all its operating markets as a precautionary measure. The statement noted that while the company identified several counterfeit units in a specific country and issued a global alert, this does not necessarily imply that the suspect batches have entered all markets. The Center further highlighted that the EDA had already issued an educational bulletin in June—supported by visual aids—regarding this medication. Finally, the EDA emphasized that its inspectors have not detected any counterfeit units of this drug within Egypt to date.

Source: Egypt Independent December 25, 2025 14:35 UTC